214610 — MiCo BioMed Co Balance Sheet
0.000.00%
Last trade - 00:00
- KR₩75bn
- KR₩95bn
- KR₩16bn
R2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 7,353 | 9,788 | 24,133 | 36,868 | 14,277 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,050 | 1,293 | 11,435 | 11,790 | 2,346 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 13,975 | 16,682 | 57,311 | 69,681 | 36,531 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 7,054 | 6,368 | 11,671 | 16,058 | 10,401 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 24,159 | 25,031 | 70,960 | 88,677 | 57,512 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2,643 | 18,377 | 8,875 | 11,723 | 27,430 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 18,447 | 24,010 | 14,998 | 36,419 | 39,819 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 5,712 | 1,021 | 55,961 | 52,259 | 17,693 |
Total Liabilities & Shareholders' Equity | 24,159 | 25,031 | 70,960 | 88,677 | 57,512 |
Total Common Shares Outstanding |